Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma

We are recently faced with a progressive evolution of the therapeutic paradigm for radioiodine refractory differentiated thyroid cancer (RAI-R DTC), since the advent of tissue agnostic inhibitors. Thus, tumor genotype assessment is always more relevant and is playing a crucial role into clinical pra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nannini, Margherita, Repaci, Andrea, Ricco, Gianluca, Ianni, Manuela, Golemi, Arber, Maiolo, Vincenzo, Ferrari, Marco, Natali, Filippo, Rizzini, Elisa Lodi, Monari, Fabio, Solaroli, Erica, De Leo, Antonio, Maloberti, Thais, Pantaleo, Maria A., De Biase, Dario, Tallini, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792137/
https://www.ncbi.nlm.nih.gov/pubmed/36578928
http://dx.doi.org/10.3389/fonc.2022.1042525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792137/
https://www.ncbi.nlm.nih.gov/pubmed/36578928
http://dx.doi.org/10.3389/fonc.2022.1042525

Ejemplares similares